KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced today that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland. The expansion of this facility was announced on October 22, 2020.

KBI and Selexis will celebrate with ribbon-cutting activities and facility tours starting in July 2022.

For more information, please visit the link below.

https://news.jsrlifesciences.com/212805-kbi-biopharma-sa-and-selexis-sa-expand-in-europe-by-opening-an-integrated-biologics-manufacturing-facility-in-geneva-switzerland